| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CURIS INC | Director | Non Qualified Stock Option | 4.25K | $49.4K | $11.62 | May 21, 2024 | Direct |
| TITAN PHARMACEUTICALS INC | Executive Chairman, Director | Option to Purchase Common Stock | 65K | Jan 5, 2022 | Direct | ||
| GALECTIN THERAPEUTICS INC | Director | Stock Option (right to buy) | 50K | Jan 24, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CRIS | CURIS INC | May 21, 2024 | 1 | $49.4K | 4 | May 23, 2024 | Director |
| GALT | GALECTIN THERAPEUTICS INC | Jan 24, 2024 | 1 | $0 | 4 | Feb 7, 2024 | Director |
| GALT | GALECTIN THERAPEUTICS INC | Jan 26, 2023 | 1 | $0 | 4 | Jan 30, 2023 | Director |
| CRIS | CURIS INC | Jan 23, 2023 | 1 | $0 | 4 | Jan 24, 2023 | Director |
| SHWZ | Medicine Man Technologies, Inc. | Oct 28, 2022 | 0 | $0 | 3/A | Dec 2, 2022 | Incorrect Filing |
| CRIS | CURIS INC | Jan 31, 2022 | 1 | $0 | 4 | Jan 31, 2022 | Director |
| GALT | GALECTIN THERAPEUTICS INC | Jan 24, 2022 | 1 | $0 | 4 | Jan 25, 2022 | Director |
| TTNP | TITAN PHARMACEUTICALS INC | Jan 5, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Executive Chairman, Director |